MFE-280
MFE-280 was derived from a recurrent, poorly differentiated endometrial carcinoma from a 78 year old patient. Initially, cells were grown as aggregates in suspension for one year, after which they were transferred to monolayer culture. The karyotype analysis revealed near-diploidy with a complex heterogeneous aberration pattern. MFE-280 were found to be positive for cytokines 7, 8, 18 and 19 as well as for vimentin. In addition, the cells express the placental protein 14, PP14. They have been shown to be tumorigenic in nude mice.
Product Specifications
Applications
For research use only
Storage Conditions
Liquid Nitrogen
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-62646R-PE-01 20 µL
OXGR1/GPR80 Recombinant Antibody, PE Conjugated
Sign In for Pricing
View Details bsm-62646R-PE-02 100 µL
OXGR1/GPR80 Recombinant Antibody, PE Conjugated
Sign In for Pricing
View Details 126221-ML405 100 µL
EIF2AK1 (Eukaryotic Translation Initiation Factor 2 alpha Kinase 1, Heme-regulated Eukaryotic Initiation Factor eIF-2-alpha Kinase, Heme-regulated Inhibitor, Heme-controlled Repressor, HCR, Hemin-sensitive Initiation Factor-2 alpha Kinase, PRO1362, HRI, KIAA1369) (MaxLight 405) discontinued
Sign In for Pricing
View Details